Description
Bifidobacterium infantis
Bifidobacterium infantis is a species of probiotic bacteria found naturally in the oral cavity and gastrointestinal tract. It is found in some foods and used in the production of certain yoghurts, sauerkraut, cheese and is often added to infant formula (1). Bifidobacterium infantis is highly prevalent in breastfed infants, primarily due to its transmission from the mother’s milk to the new-born.
Bifidobacterium infantis plays a crucial role in the gut microbiome. It works in synergy with other gut bacteria to extract energy from non-digestible nutrients, resulting in the production of butyrate. Butyrate is a short-chain fatty acid that nourishes the cells lining the colon and is linked to numerous health benefits. Moreover, Bifidobacterium infantis occupies a significant space in the gut microbiome, preventing the colonisation of harmful microorganisms that could otherwise cause disease (2). Studies have also shown that Bifidobacterium infantis can help alleviate symptoms associated with various gastrointestinal disorders such as irritable bowel syndrome and ulcerative colitis (1).
If pregnant, have a weakened immune system, or are on certain antibiotics, please consult your health care practitioner before using this product.
Epigenetics probiotic Bifidobacterium infantis is produced in a vegan friendly and convenient delayed release capsule. Recommended daily dose is 1 serving per day taken after a meal, or as directed by a healthcare practitioner. This product is not intended to be used as an alternative to a varied diet.
Ingredients
| Ingredient |
Amount per serving |
ECRDA* |
%DV* |
| Inulin (from Jerusalem artichoke) |
375 mg |
† |
† |
| Bifidobacterium infantis |
50 mg (5B CFU) |
† |
† |
† Percent Daily Reference Intakes (RI) not established.
INGREDIENTS: Organic Jerusalem artichoke tuber extract (Helianthus tuberosus), Delayed release vegetable capsule (Hydroxypropyl methylcellulose, Gellan gum), Bifidobacterium infantis.
Suitable for vegans
Read More
Bifidobacterium infantis is a unique gut bacterium that has adapted to colonise the human gut at an early stage, potentially even before birth. Its primary function is to break down complex carbohydrates that are indigestible by human cells. Breast milk, a primary food source for infants, contains Human Milk Oligosaccharides (HMO), a collection of non-digestible carbohydrates that are difficult to break down but are highly nutritious. Bifidobacterium infantis possesses the necessary tools encoded in its DNA to break down HMOs and make their useful components available to other gut bacteria and human cells. One such useful product is butyrate, a short-chain fatty acid that regulates blood sugar levels and is one of the three main SCFAs produced in the gut microbiome. Bifidobacterium infantis’s unique ability to break down HMOs and produce butyrate is crucial for maintaining a healthy gut and overall wellbeing (2).
Likewise, Bifidobacterium infantis has a significant advantage in a baby’s gut due to its ability to extract essential nutrients from HMOs. As formula or breast milk is a primary food source for infants, Bifidobacterium infantis can thrive and take up a considerable amount of space in the microbiome. This bacterium’s ability to outcompete other microbes in the gut allows it to play a crucial role in maintaining an infant’s health by preventing harmful bacteria from colonising the gut (2).
Bifidobacterium infantis is known to produce short chain fatty acids in the gut, including acetic acid. Acetic acid is beneficial in nourishing the intestinal lining and helping to ward off invading pathogens such as yeast and fungus, which can cause infections. In new-borns, Bifidobacterium infantis plays a critical role in promoting the production of proteins that fill gaps between intestinal cells and strengthen the gut lining as the baby grows. Additionally, Bifidobacterium infantis helps to prevent harmful bacteria from causing gut dysbiosis by outcompeting them. It also aids in the breakdown of sugars in breast milk and the production of folate, a crucial nutrient for healthy red blood cell production and DNA synthesis and repair (3).
Furthermore, studies have shown that Bifidobacterium infantis can help to alleviate symptoms associated with various gastrointestinal disorders. For example, it has been shown to be effective in reducing symptoms of irritable bowel syndrome, such as bloating, flatulence, and abdominal pain (1). It is thought to achieve this by modulating the gut microbiota and reducing inflammation in the gut.
Probiotics are generally considered safe for most individuals to consume however in rare cases, individuals with underlying medical conditions may experience systemic infections as a result of probiotic use. Its also worth noting that Bifidobacterium infantis is sensitive to several commonly prescribed antibiotics, including tobramycin, ciprofloxacin, and vancomycin (1). It is therefore crucial to consult with your healthcare practitioner if you have a compromised immune system, are pregnant or are on antibiotics to avoid potential complications.
Reviews
There are no reviews yet.